This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shenzhen Salubris Pharmaceuticals Co. Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Jianqiong Zhi in Pharmaceutical Science
Introduction: Jianqiong Zhi is an esteemed inventor based in Shenzhen, China, recognized for his contributions to the field of pharmaceutical innovations. His work primarily focuses on developing advanced therapeutic solutions aimed at combating significant health issues, including heart failure.
Latest Patents: Jianqiong Zhi holds a patent for a remarkable invention titled "Angiotensin II receptor antagonist metabolite and NEP inhibitor composite and preparation method thereof." This patent introduces a supramolecular composite that includes an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The innovative aspect of this invention lies in its application as a pharmaceutical product tailored for treating heart failure.
Career Highlights: Throughout his career, Jianqiong Zhi has established himself as a valuable asset in the pharmaceutical industry. He is currently affiliated with Shenzhen Salubris Pharmaceuticals Co. Ltd., a company known for its commitment to research and development in innovative therapies. His inventive spirit and dedication have made significant advancements in the pharmaceutical landscape, focusing on improving patient care and treatment outcomes.
Collaborations: Jianqiong Zhi collaborates with talented professionals, including Jie Gandalf Yan and Wenjie Xu, who contribute to the innovative culture at Shenzhen Salubris Pharmaceuticals Co. Ltd. Their combined expertise fosters a creative environment essential for pioneering new pharmaceutical solutions.
Conclusion: Jianqiong Zhi's work exemplifies the intersection of innovation and healthcare. His contributions through patents and collaborative efforts are a testament to his commitment to advancing therapeutic options for patients suffering from heart failure. As he continues to explore new horizons in pharmaceutical science, his work promises to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile